AI Bias Analysis
4 models · Takes ~15 seconds
Steve Ubl, chief executive of PhRMA, plans to step down at the end of the year, after more than a decade leading the main trade group for brand-name drug makers
Source
Stat News
Opens original article in a new tab
Democrats are focused on health care affordability as costs keep climbing.
(MedPage Today) -- Emerging data presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting highlighted the continued progress in targeted therapies for systemic mastocytosis, including next-generation approaches...
CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.
In this edition of Health Tech: FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.
